Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03090737
Title Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer (CheckMate 907)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

lung non-small cell carcinoma

Therapies

Nivolumab

Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Alabama Oncology Birmingham Alabama 35205 United States Details
Los Angeles Hematology Oncology Medical Group Los Angeles California 90017 United States Details
St Vincent Frontier Cancer Center Billings Montana 59102 United States Details
Broome Oncology Johnson City New York 13790 United States Details
Guthrie Medical Group Sayre Sayre Pennsylvania 18840 United States Details
Local Institution - 0015 Kingston Ontario K7L 2V7 Canada Details
Local Institution - 0014 Oshawa Ontario L1G 2B9 Canada Details
Local Institution - 0001 Toronto Ontario M5G 2M9 Canada Details
Local Institution - 0017 Nagoya Aichi 4648681 Japan Details
Local Institution - 0023 Osaka-shi Osaka 5418567 Japan Details
Local Institution - 0018 Koto-ku Tokyo 1358550 Japan Details
Local Institution - 0016 Tokyo 1040045 Japan Details
Local Institution - 0003 Craiova 200347 Romania Details
Local Institution - 0006 Sector 2 022328 Romania Details
Local Institution - 0011 Port Elizabeth Eastern Cape 6045 South Africa Details
Local Institution - 0013 Parktown, Johannesburg Gauteng 2193 South Africa Details
Local Institution - 0012 George Western CAPE 6530 South Africa Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field